| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.677 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.901 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 coding SNVs) | 0.572 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 coding SNVs) | 0.843 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 intronic SNVs) | 0.424 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 intronic SNVs) | 0.888 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 noncoding SNVs) | 0.903 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 noncoding SNVs) | 0.974 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 splice region SNVs) | 0.918 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 splice region SNVs) | 0.959 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.533 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.845 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 coding SNVs) | 0.333 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 coding SNVs) | 0.768 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 noncoding SNVs) | 0.786 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 noncoding SNVs) | 0.91 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) indels) | 0.995 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) indels) | 0.983 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) microsatellite variants) | 0.987 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) microsatellite variants) | 0.982 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.95 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.97 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding indels) | 0.952 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding indels) | 0.904 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding microsatellite variants) | 0.812 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding microsatellite variants) | 0.842 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, far from splice site) | 0.948 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, far from splice site) | 0.911 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, highly conserved) | 0.974 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, highly conserved) | 0.79 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, moderately conserved) | 0.914 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, moderately conserved) | 0.813 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, not conserved) | 0.835 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, not conserved) | 0.757 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, poorly conserved) | 0.889 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, poorly conserved) | 0.82 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs) | 0.889 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs) | 0.841 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.885 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.841 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.918 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.776 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.667 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.83 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, near splice site) | 0.931 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, near splice site) | 0.827 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, not conserved) | 0.52 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, not conserved) | 0.868 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.602 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.86 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs) | 0.6 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs) | 0.909 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.311 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.92 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding indels) | 0.917 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding indels) | 0.971 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding microsatellite variants) | 0.833 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding microsatellite variants) | 0.997 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, far from splice site) | 0.744 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, far from splice site) | 0.923 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, highly conserved) | 0.974 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, highly conserved) | 0.949 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, intergenic) | 0.875 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, intergenic) | 0.75 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, moderately conserved) | 0.862 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, moderately conserved) | 0.958 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, near splice site) | 0.963 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, near splice site) | 0.968 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, not conserved) | 0.362 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, not conserved) | 0.799 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, poorly conserved) | 0.498 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, poorly conserved) | 0.893 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.343 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.855 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.994 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.965 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.775 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.874 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.792 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.941 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, near splice site) | 0.997 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, near splice site) | 0.988 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.356 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.848 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.554 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.897 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.85 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.815 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB exonic SNVs) | 0.523 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | Evo 2 40B (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB exonic SNVs) | 0.684 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.285 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 'Both' (coding and noncoding) SNVs) | 0.55 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 coding SNVs) | 0.212 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 coding SNVs) | 0.509 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 intronic SNVs) | 0.072 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 intronic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 intronic SNVs) | 0.688 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 noncoding SNVs) | 0.451 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 noncoding SNVs) | 0.649 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA1 splice region SNVs) | 0.611 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA1 splice region SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA1 splice region SNVs) | 0.634 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.176 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 'Both' (coding and noncoding) SNVs) | 0.514 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 coding SNVs) | 0.134 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 coding SNVs) | 0.501 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; BRCA2 noncoding SNVs) | 0.361 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot BRCA2 noncoding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; BRCA2 noncoding SNVs) | 0.555 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) indels) | 0.852 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) indels) | 0.505 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) microsatellite variants) | 0.461 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) microsatellite variants) | 0.53 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.426 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar 'Both' (coding and noncoding) SNVs) | 0.506 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding indels) | 0.701 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding indels) | 0.503 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding microsatellite variants) | 0.171 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding microsatellite variants) | 0.535 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, far from splice site) | 0.671 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, far from splice site) | 0.507 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, highly conserved) | 0.937 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, highly conserved) | 0.521 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, moderately conserved) | 0.694 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, moderately conserved) | 0.517 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, not conserved) | 0.577 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, not conserved) | 0.52 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding non-SNVs, poorly conserved) | 0.568 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding non-SNVs, poorly conserved) | 0.501 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs) | 0.659 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs) | 0.505 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.649 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, far from splice site) | 0.506 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.797 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, highly conserved) | 0.501 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.323 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, moderately conserved) | 0.514 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, near splice site) | 0.777 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, near splice site) | 0.509 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, not conserved) | 0.144 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, not conserved) | 0.545 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.193 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar coding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar coding SNVs, poorly conserved) | 0.526 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs) | 0.016 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) non-SNVs) | 0.51 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.005 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar low SpliceAI and Pangolin scores (both below 0.1) SNVs) | 0.52 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding indels classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding indels) | 0.177 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding indels classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding indels) | 0.505 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding microsatellite variants) | 0.036 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding microsatellite variants classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding microsatellite variants) | 0.786 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, far from splice site) | 0.044 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, far from splice site) | 0.518 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, highly conserved) | 0.732 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, highly conserved) | 0.503 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, intergenic) | 0.729 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, intergenic) | 0.625 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, moderately conserved) | 0.164 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, moderately conserved) | 0.502 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, near splice site) | 0.5 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, near splice site) | 0.519 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, not conserved) | 0.047 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, not conserved) | 0.584 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding non-SNVs, poorly conserved) | 0.024 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding non-SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding non-SNVs, poorly conserved) | 0.543 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.014 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, far from splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, far from splice site) | 0.51 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.92 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, highly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, highly conserved) | 0.552 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.216 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, intergenic classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, intergenic) | 0.655 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.077 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, moderately conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, moderately conserved) | 0.523 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, near splice site) | 0.841 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, near splice site classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, near splice site) | 0.533 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.011 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, not conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, not conserved) | 0.516 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.023 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot ClinVar noncoding SNVs, poorly conserved classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; ClinVar noncoding SNVs, poorly conserved) | 0.502 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.601 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB 'Both' (coding and noncoding) SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB 'Both' (coding and noncoding) SNVs) | 0.491 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUPRC (zero-shot; SpliceVarDB exonic SNVs) | 0.385 |
|---|
| Genome modelling and design across all domains of life with Evo 2: Supplementary Data 1, human variant effect prediction results (Nature 2026); Genome modelling and design across all domains of life with Evo 2: Supplementary Information (Nature 2026); evo2: Journal full-text XML | NT (Evo 2 paper variant effect evaluations) | Zero-shot SpliceVarDB exonic SNVs classification (Evo 2 paper, Supplementary Data 1) | AUROC (zero-shot; SpliceVarDB exonic SNVs) | 0.49 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Evo 2 (40B) (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, Aptamer | Spearman (mean signed Spearman over the 2 Aptamer assays) | 0.097 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Evo 2 (40B) (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, macro over 3 ncRNA categories | Spearman (macro-mean over 3 ncRNA categories (equal category weights)) | 0.212 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Evo 2 (40B) (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, Ribozyme | Spearman (mean signed Spearman over the 26 Ribozyme assays) | 0.108 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Evo 2 (40B) (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, tRNA | Spearman (mean signed Spearman over the 3 tRNA assays) | 0.431 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Nucleotide Transformer (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, Aptamer | Spearman (mean signed Spearman over the 2 Aptamer assays) | -0.0886 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Nucleotide Transformer (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, macro over 3 ncRNA categories | Spearman (macro-mean over 3 ncRNA categories (equal category weights)) | 0.12 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Nucleotide Transformer (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, Ribozyme | Spearman (mean signed Spearman over the 26 Ribozyme assays) | 0.133 |
|---|
| RNAGym fitness leaderboard (v0.1.1), leaderboard/fitness/README.md | Nucleotide Transformer (RNAGym fitness leaderboard v0.1.1) | RNAGym v0.1.1 fitness, signed Spearman, tRNA | Spearman (mean signed Spearman over the 3 tRNA assays) | 0.317 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, All variants) | 0.969 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, All variants) | 0.793 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Intron (Non-splice)) | 0.903 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Intron (Non-splice)) | 0.75 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) | 0.835 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & Intron (Non-splice)) | 0.664 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) | 0.896 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense & 3'UTR) | 0.546 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense) | 0.836 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Missense) | 0.594 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Noncoding) | 0.975 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Noncoding) | 0.851 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, RNA gene) | 0.459 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, RNA gene) | 0.371 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Splice) | 0.697 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Splice) | 0.617 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Start loss) | 0.711 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Start loss) | 0.569 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop gain) | 0.663 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop gain) | 0.618 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop loss) | 0.826 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Stop loss) | 0.609 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Synonymous) | 0.885 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, Synonymous) | 0.77 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 3' UTR) | 0.747 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 3' UTR) | 0.564 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Evo 2 7B base, 8,192 bp log-likelihood ratio (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 5' UTR) | 0.767 |
|---|
| Genomic heterogeneity inflates the performance of variant pathogenicity predictions (Lu, Liu, Lin and Brandes, bioRxiv 2025, v2) | Nucleotide Transformer 2.5B multi-species, CLS embedding L2 distance (Lu et al. 2025) | ClinVar pathogenic versus benign SNVs within variant type, AUROC (Lu et al. 2025) | AUROC (ClinVar pathogenic vs benign SNVs, 5' UTR) | 0.567 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench ECLIP: eCLIP binding site prediction | AUPRC | 47.3 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench GO: Gene Ontology term prediction | AUPRC | 46.7 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench HL: mRNA half life | Pearson | 0.66 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench MRL-HL-PAIR: Paired mean ribosome load and half life | Pearson | 0.51 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench MRL-MPRA: Mean ribosome load on an MPRA library | Pearson | 0.7 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench MRL: Mean ribosome load | Pearson | 0.45 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench MRNA-LOC-LR: mRNA localisation, long range | AUPRC | 79.5 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench MRNA-LOC-SR: mRNA localisation, short range | AUPRC | 76.7 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | Evo2 | mRNABench PROT-LOC: Protein localisation | AUPRC | 40.8 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench ECLIP: eCLIP binding site prediction | AUPRC | 40.5 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench GO: Gene Ontology term prediction | AUPRC | 36 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench HL: mRNA half life | Pearson | 0.57 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench MRL-HL-PAIR: Paired mean ribosome load and half life | Pearson | 0.57 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench MRL-MPRA: Mean ribosome load on an MPRA library | Pearson | 0.6 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench MRL: Mean ribosome load | Pearson | 0.34 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench MRNA-LOC-LR: mRNA localisation, long range | AUPRC | 76.6 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench MRNA-LOC-SR: mRNA localisation, short range | AUPRC | 72.2 |
|---|
| mRNABench: A curated benchmark for mature mRNA property and function prediction | NT | mRNABench PROT-LOC: Protein localisation | AUPRC | 32 |
|---|